First-in-Human trial begins for hepatitis c vaccine
NCT ID NCT07237282
Summary
This early-stage study aims to test the safety and immune response of an experimental Hepatitis C vaccine in healthy adults. The vaccine is designed to prevent Hepatitis C infection, which currently has no available vaccine and affects millions worldwide. Researchers will monitor participants for side effects and measure how well their bodies produce protective antibodies after vaccination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ottawa Hospital - General Campus
Ottawa, Ontario, K1H 8L6, Canada
Contact
-
Toronto General Hospital - Toronto Centre for Liver Disease
Toronto, Ontario, M5G 2C4, Canada
Contact
-
University of Alberta Hospital
Edmonton, Alberta, T6G 2B7, Canada
Contact
Conditions
Explore the condition pages connected to this study.